ID22389A - Komposisi dan metode untuk menurunkan hipertensi okuler - Google Patents

Komposisi dan metode untuk menurunkan hipertensi okuler

Info

Publication number
ID22389A
ID22389A IDW991029A ID991029A ID22389A ID 22389 A ID22389 A ID 22389A ID W991029 A IDW991029 A ID W991029A ID 991029 A ID991029 A ID 991029A ID 22389 A ID22389 A ID 22389A
Authority
ID
Indonesia
Prior art keywords
composition
methods
reduce
occular hypertension
occular
Prior art date
Application number
IDW991029A
Other languages
English (en)
Indonesian (id)
Inventor
Kenneth Warren Reed
Shau-Fong Yen
Mary Sou
Regina Flinn Peacock
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=38729083&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ID22389(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of ID22389A publication Critical patent/ID22389A/id

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A61K31/5575—Eicosanoids, e.g. leukotrienes or prostaglandins having a cyclopentane, e.g. prostaglandin E2, prostaglandin F2-alpha
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Ophthalmology & Optometry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
IDW991029A 1997-03-17 1998-03-13 Komposisi dan metode untuk menurunkan hipertensi okuler ID22389A (id)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US81922197A 1997-03-17 1997-03-17

Publications (1)

Publication Number Publication Date
ID22389A true ID22389A (id) 1999-10-07

Family

ID=38729083

Family Applications (1)

Application Number Title Priority Date Filing Date
IDW991029A ID22389A (id) 1997-03-17 1998-03-13 Komposisi dan metode untuk menurunkan hipertensi okuler

Country Status (33)

Country Link
EP (1) EP0969846B2 (xx)
JP (2) JP4920124B2 (xx)
KR (1) KR100555818B1 (xx)
CN (1) CN1236775C (xx)
AR (2) AR002194A1 (xx)
AT (1) ATE257385T1 (xx)
AU (1) AU738781B2 (xx)
BR (2) BR9808016A (xx)
CA (1) CA2280089C (xx)
CL (1) CL2009001870A1 (xx)
CO (1) CO4940427A1 (xx)
CY (1) CY2526B1 (xx)
CZ (1) CZ299833B6 (xx)
DE (1) DE69820997T3 (xx)
DK (1) DK0969846T4 (xx)
EE (1) EE04091B1 (xx)
ES (1) ES2214706T5 (xx)
HK (1) HK1026841A1 (xx)
HU (1) HU228896B1 (xx)
ID (1) ID22389A (xx)
IL (1) IL131041A0 (xx)
MY (1) MY122237A (xx)
NO (1) NO327713B1 (xx)
NZ (1) NZ337322A (xx)
PE (1) PE61899A1 (xx)
PL (1) PL197509B1 (xx)
PT (1) PT969846E (xx)
RU (1) RU2197970C2 (xx)
SI (1) SI0969846T2 (xx)
TW (1) TW527187B (xx)
UA (1) UA63938C2 (xx)
WO (1) WO1998041208A1 (xx)
ZA (1) ZA982188B (xx)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6011062A (en) * 1994-12-22 2000-01-04 Alcon Laboratories, Inc. Storage-stable prostaglandin compositions
AR002194A1 (es) * 1997-03-17 1998-01-07 Sanchez Reynaldo Alemany Instrumento computarizado para el analisis del movimiento.
US6187818B1 (en) 1998-06-17 2001-02-13 Pharmacia & Upjohn Company Prostaglandins formulation and process
JP4880808B2 (ja) * 1999-11-15 2012-02-22 久光製薬株式会社 人工涙液型点眼剤組成物
JP4000505B2 (ja) * 1999-12-01 2007-10-31 第一三共株式会社 緑内障を治療するための併用剤
ATE490761T1 (de) * 2000-09-13 2010-12-15 Santen Pharmaceutical Co Ltd Augentropfen
WO2002045748A1 (fr) * 2000-12-05 2002-06-13 Sankyo Company, Limited Compositions d'abaissement de la tension oculaire pour administration topique
US20020198209A1 (en) * 2001-05-03 2002-12-26 Allergan Sales Inc. Compositions having enhanced pharmacokinetic characteristics
US7074827B2 (en) * 2002-10-24 2006-07-11 Sucampo Ag (Usa) Inc. Method for treating ocular hypertension and glaucoma
TWI339659B (en) * 2004-03-18 2011-04-01 R Tech Ueno Ltd Aqueous composition comprising thiazole derivative
US8569367B2 (en) * 2004-11-16 2013-10-29 Allergan, Inc. Ophthalmic compositions and methods for treating eyes
GB0501192D0 (en) * 2005-01-20 2005-03-02 Resolution Chemicals Ltd Stable prostaglandin-containing compositions
US7851504B2 (en) * 2005-03-16 2010-12-14 Allergan, Inc. Enhanced bimatoprost ophthalmic solution
JP5252787B2 (ja) * 2005-08-02 2013-07-31 参天製薬株式会社 熱的に不安定な薬物の分解抑制方法
US8030349B2 (en) * 2005-08-02 2011-10-04 Santen Pharmaceutical Co., Ltd. Method for prevention of degradation of thermally unstable medicament
JP2007099647A (ja) * 2005-09-30 2007-04-19 Kobayashi Pharmaceut Co Ltd 粘膜適用組成物
US8168206B1 (en) 2005-10-06 2012-05-01 Allergan, Inc. Animal protein-free pharmaceutical compositions
WO2007105691A1 (ja) * 2006-03-13 2007-09-20 R-Tech Ueno, Ltd. 水性組成物
EP2010143B1 (en) * 2006-03-17 2015-08-12 Johnson & Johnson Vision Care, Inc. Stabilized ophthalmic compositions comprising oxidatively unstable components
ZA200902453B (en) * 2006-10-31 2010-07-28 Alcon Res Ltd PAI-1 binding modulators for the treatment of ocular disorders
JPWO2008096804A1 (ja) * 2007-02-07 2010-05-27 テイカ製薬株式会社 ラタノプロスト含有点眼剤
JP2009073788A (ja) * 2007-09-21 2009-04-09 Teika Seiyaku Kk イソプロピルウノプロストン含有眼用組成物
MX2010003774A (es) * 2007-10-08 2010-04-27 Fovea Pharmaceuticals Sa Formulaciones oftalmicas acuosas.
TWI544927B (zh) * 2008-03-17 2016-08-11 愛爾康研究有限公司 具有低濃度的表面活性劑以促進治療劑之生物可利用性的藥學組成物
AU2009225931B9 (en) * 2008-03-17 2014-04-03 Novartis Ag Aqueous pharmaceutical compositions containing borate-polyol complexes
EP2127638A1 (en) 2008-05-30 2009-12-02 Santen Pharmaceutical Co., Ltd Method and composition for treating ocular hypertension and glaucoma
US8952051B2 (en) * 2009-11-05 2015-02-10 Allergan, Inc. Ophthalmic formulations containing substituted gamma lactams and methods for use thereof
EP2696876A4 (en) * 2011-04-12 2014-09-03 R Tech Ueno Ltd AQUEOUS OPHTHALMIC COMPOSITION
US20130029919A1 (en) * 2011-07-26 2013-01-31 Allergan, Inc. Two part formulation system for opthalmic delivery
EP2567689A1 (en) 2011-09-12 2013-03-13 Visiotact Pharma Ophthtalmic compositions comprising prostaglandin F2 alpha derivatives and hyaluronic acid
US8957048B2 (en) 2011-10-06 2015-02-17 Allergan, Inc. Compositions for the treatment of dry eye
PT2787969T (pt) 2011-12-07 2021-11-09 Allergan Inc Entrega eficiente de lípidos para o filme lacrimal humano utilizando um sistema de emulsão sensível ao sal
US9907826B2 (en) 2011-12-07 2018-03-06 Allergan, Inc. Efficient lipid delivery to human tear film using a salt-sensitive emulsion system
US10279005B2 (en) 2014-11-25 2019-05-07 Allergan, Inc. Stabilized omega-3 ophthalmic compositions
AU2019343188A1 (en) * 2018-09-21 2021-05-20 Aufbau Medical Innovations Limited Compositions and methods for glaucoma
US11312922B2 (en) 2019-04-12 2022-04-26 Ecolab Usa Inc. Antimicrobial multi-purpose cleaner comprising a sulfonic acid-containing surfactant and methods of making and using the same

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0458587T3 (da) * 1990-05-22 1993-08-23 R Tech Ueno Ltd Behandling af okulær hypertension med en synergistisk kombination til ophthalmisk anvendelse
US5767154A (en) * 1991-02-07 1998-06-16 Allergan 5-trans-prostaglandins of the F series and their use as ocular hypotensives
WO1992013836A1 (en) * 1991-02-07 1992-08-20 Allergan, Inc. 2-decarboxyl-2-hydroxyalkyl-5-trans prostaglandin f derivatives
CN1129400A (zh) * 1994-05-06 1996-08-21 阿尔康实验室公司 维生素e生育酚衍生物在眼科组合物中的应用
US5631287A (en) † 1994-12-22 1997-05-20 Alcon Laboratories, Inc. Storage-stable prostaglandin compositions
US5558876A (en) * 1995-03-29 1996-09-24 Alcon Laboratories, Inc. Topical ophthalmic acidic drug formulations
AR002194A1 (es) * 1997-03-17 1998-01-07 Sanchez Reynaldo Alemany Instrumento computarizado para el analisis del movimiento.

Also Published As

Publication number Publication date
JP4920124B2 (ja) 2012-04-18
AR011192A1 (es) 2000-08-02
RU2197970C2 (ru) 2003-02-10
NZ337322A (en) 2001-05-25
JP2001515502A (ja) 2001-09-18
HUP0002194A2 (hu) 2000-12-28
AU738781B2 (en) 2001-09-27
HU228896B1 (en) 2013-06-28
DK0969846T4 (da) 2010-12-20
NO994481D0 (no) 1999-09-16
EE04091B1 (et) 2003-08-15
HK1026841A1 (en) 2000-12-29
DE69820997T2 (de) 2004-12-09
ES2214706T5 (es) 2011-02-02
CZ325799A3 (cs) 2000-01-12
EP0969846B1 (en) 2004-01-07
SI0969846T2 (sl) 2010-12-31
SI0969846T1 (en) 2004-06-30
DK0969846T3 (da) 2004-04-13
NO994481L (no) 1999-09-16
CL2009001870A1 (es) 2010-01-22
CZ299833B6 (cs) 2008-12-10
AU7035398A (en) 1998-10-12
DE69820997T3 (de) 2011-10-06
KR20000076330A (ko) 2000-12-26
BRPI9816218B1 (pt) 2016-04-12
JP2010043110A (ja) 2010-02-25
ZA982188B (en) 1998-09-17
EP0969846A1 (en) 2000-01-12
CN1249687A (zh) 2000-04-05
CO4940427A1 (es) 2000-07-24
CN1236775C (zh) 2006-01-18
PT969846E (pt) 2004-05-31
CY2526B1 (en) 2006-02-08
UA63938C2 (uk) 2004-02-16
PL197509B1 (pl) 2008-04-30
EP0969846B2 (en) 2010-08-25
DE69820997D1 (de) 2004-02-12
IL131041A0 (en) 2001-01-28
WO1998041208A1 (en) 1998-09-24
EE9900410A (et) 2000-04-17
HUP0002194A3 (en) 2012-08-28
KR100555818B1 (ko) 2006-03-03
ATE257385T1 (de) 2004-01-15
CA2280089C (en) 2009-03-03
TW527187B (en) 2003-04-11
PE61899A1 (es) 1999-06-30
CA2280089A1 (en) 1998-09-24
AR002194A1 (es) 1998-01-07
MY122237A (en) 2006-04-29
ES2214706T3 (es) 2004-09-16
NO327713B1 (no) 2009-09-14
BR9808016A (pt) 2000-03-08
PL335168A1 (en) 2000-04-10

Similar Documents

Publication Publication Date Title
ID22389A (id) Komposisi dan metode untuk menurunkan hipertensi okuler
ID17437A (id) Metoda dan komposisi untuk membuat kulit terang
ID22889A (id) Komposisi kopolimer etilena dan penggunaannya
ID20400A (id) Komposisi dan metoda untuk menghambat penuaan akibat cahaya pada kulit
ID19586A (id) Komposisi-komposisi gelas silika-soda-kapur dan pemakaiannya
NO20012512D0 (no) Sammensetning av dieseldrivstoff
ID22957A (id) Senyawa dan penggunaannya
ID19422A (id) Piridina dan bifenil tersubstitusi
DE69733395D1 (de) Motorzusammensetzung
ID23684A (id) Komposisi-polimer-organoclay dan pembuatannya
ID26964A (id) Komposisi dan metode untuk pengaturan pengaktifan limfosit
ID24196A (id) Komposisi dan penggunaan
ID21859A (id) Bahan lembaran serupa-kulit dan metode untuk memproduksi bahan tersebut
ID24314A (id) Tempat umpan bersekat-sekat
ID27324A (id) Komposisi pewarna rambut dan penggunaannya
DE69800435D1 (de) Feste kosmetische Zusammensetzung sowie ihre Verwendungen
ID24610A (id) Radas serta metode untuk mengkristalisasian
ID16889A (id) Senyawa turunan alkilaminobenzotiazol dan benzoksazol
ID24872A (id) Komposisi pengawet berdasarkan senyawa donor formaldehide dan iodopropinil
ID20819A (id) Semaforin l manusia (h-sema l) dan semaforin yang sesuai dalam spesies lainnya
DE69800212D1 (de) Feste kosmetische Zusammensetzung sowie ihre Verwendungen
ID25848A (id) Komposisi-komposisi dan metode-metode herbisida sinergis
IT1290561B1 (it) Procedimento per riconoscere mancate combustioni
ID18459A (id) Produksi-bersama 6-aminokapronitril dan heksametilenadiamina
ID21847A (id) Komposisi insektisida dan metoda penggunaannya